Bruce S. Alpert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Bruce S. Alpert has a total of 28 co-authors. Here are the top co-authors by number of shared publications:
Richard A. Dart
Marshfield Clinic Research Institute, Marshfield Clinic Health Systems, Marshfield, Wisconsin
3 shared publicationsDavid Quinn
Department of Mathematics, Welch Allyn, Skaneateles Falls
2 shared publicationsPaul M. Matsumura
SunTech Medical, Inc., Morrisville, North Carolina, USA
2 shared publicationsBrittany Hedge
Department of Pediatric Surgery, McGovern Medical School at the University of Texas Health Science Center at Houston, Houston, TX 77030, USA
1 shared publicationBruce C. Friedman
GE Healthcare, Jasper, GA, USA
1 shared publicationBruce Friedman
Independent Consultant, Big Canoe, Georgia, USA
1 shared publication
Latest Publications
- Open Access
- 6 April 2024
- Published by Open Exploration Publishing
- Vol. 2 (2) , 40-48
Role of cardio-ankle vascular index as a predictor of left ventricular hypertrophy in the evaluation of pediatric hypertension
Aim: Cardio-ankle vascular index (CAVI) is a marker of arterial stiffness independent of blood pressure (BP) at the time of measurement. This work sought to evaluate the association of CAVI with left ventricular hypertrophy (LVH), a marker of long-standing hypertension (HTN) in the pediatric population. Methods: CAVI values from 236 children being evaluated for HTN were compared with their BP grade (normal, elevated, stage I HTN, and stage II HTN) in accordance with clinical guidelines. CAVI values were correlated to the presence of LVH and lipid profiles. One hundred seven of the studied patients had transthoracic echocardiograms available for comparison, and 126 had available lipid results. CAVI means between the groups were compared using analysis of variance. Results: There was no significant difference in CAVI values between the BP groups [median/interquartile range: normal BP (4.95/4.4–5.7), elevated BP (5.1/4.5–5.6), stage I/II HTN (5.0/4.3–5.5)]. Mean CAVI value was higher in the group that had LVH (5.53, standard deviation = 1.4 vs. 5.1, standard deviation = 1; P = 0.13) but was not statistically significant. However, higher mean CAVI value in children ≥ 15 years was significantly associated with the presence of LVH (5.9, standard deviation = 1.8 vs. 5.2 standard deviation = 0.8; P = 0.018). Conclusions: In post-pubertal children, CAVI may be a good predictor of LVH from long-standing HTN. This tool could prove useful in screening for the presence of atherosclerotic changes and provide opportunity for intervention/improved long-term outcomes.
- 6 April 2024
- Published by Open Exploration Publishing
- Vol. 2 (2) , 40-48
Open AccessRole of cardio-ankle vascular index as a predictor of left ventricular hypertrophy in the evaluation of pediatric hypertension
Aim: Cardio-ankle vascular index (CAVI) is a marker of arterial stiffness independent of blood pressure (BP) at the time of measurement. This work sought to evaluate the association of CAVI with left ventricular hypertrophy (LVH), a marker of long-standing hypertension (HTN) in the pediatric population. Methods: CAVI values from 236 children being evaluated for HTN were compared with their BP grade (normal, elevated, stage I HTN, and stage II HTN) in accordance with clinical guidelines. CAVI values were correlated to the presence of LVH and lipid profiles. One hundred seven of the studied patients had transthoracic echocardiograms available for comparison, and 126 had available lipid results. CAVI means between the groups were compared using analysis of variance. Results: There was no significant difference in CAVI values between the BP groups [median/interquartile range: normal BP (4.95/4.4–5.7), elevated BP (5.1/4.5–5.6), stage I/II HTN (5.0/4.3–5.5)]. Mean CAVI value was higher in the group that had LVH (5.53, standard deviation = 1.4 vs. 5.1, standard deviation = 1; P = 0.13) but was not statistically significant. However, higher mean CAVI value in children ≥ 15 years was significantly associated with the presence of LVH (5.9, standard deviation = 1.8 vs. 5.2 standard deviation = 0.8; P = 0.018). Conclusions: In post-pubertal children, CAVI may be a good predictor of LVH from long-standing HTN. This tool could prove useful in screening for the presence of atherosclerotic changes and provide opportunity for intervention/improved long-term outcomes.
- Open Access
Validation of the LINEAR deflation algorithm of the Midmark IQvitals Zone Vital Signs Monitor: improving patient comfort from quicker BP acquisition
Objectives: To assess the accuracy of the Midmark IQvitals ® Zone™ wireless vital signs monitor LINEAR deflation algorithm to the requirements of the ANSI/AAMI/ISO 81060-2 Standard and the British Hypertension Society (BHS) Protocol. Methods: The Standard and BHS testing each call for ≥ 85 subjects with requirements for gender, blood pressure (BP), and arm circumference. The testers performing auscultation were blinded. Statistical calculations as per requirements were performed. Results: The mean ± SD for the 81060-2 Criterion 1 were 1.98 ± 6.90 mmHg for systolic and 0.54 ± 5.79 mmHg for diastolic BP. The Criterion 2 SD values were 5.60 mmHg for systolic and 5.26 mmHg for diastolic BP. All of these values passed the Standard requirements. The overall BHS rating was AA. Conclusions: The Midmark LINEAR algorithm is validated based on the results. Use of the algorithm results in shorter cuff deflation times, thus improving patient comfort. The LINEAR algorithm has multiple features to improve BP measurement accuracy in critical patient populations.
Open AccessValidation of the LINEAR deflation algorithm of the Midmark IQvitals Zone Vital Signs Monitor: improving patient comfort from quicker BP acquisition
Objectives: To assess the accuracy of the Midmark IQvitals ® Zone™ wireless vital signs monitor LINEAR deflation algorithm to the requirements of the ANSI/AAMI/ISO 81060-2 Standard and the British Hypertension Society (BHS) Protocol. Methods: The Standard and BHS testing each call for ≥ 85 subjects with requirements for gender, blood pressure (BP), and arm circumference. The testers performing auscultation were blinded. Statistical calculations as per requirements were performed. Results: The mean ± SD for the 81060-2 Criterion 1 were 1.98 ± 6.90 mmHg for systolic and 0.54 ± 5.79 mmHg for diastolic BP. The Criterion 2 SD values were 5.60 mmHg for systolic and 5.26 mmHg for diastolic BP. All of these values passed the Standard requirements. The overall BHS rating was AA. Conclusions: The Midmark LINEAR algorithm is validated based on the results. Use of the algorithm results in shorter cuff deflation times, thus improving patient comfort. The LINEAR algorithm has multiple features to improve BP measurement accuracy in critical patient populations.
- 4 April 2023
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 28 (3) , 167-170
Statistical considerations for testing automated sphygmomanometers in special patient populations
The International Standards Organization 81060-2:2018 is the current global Standard for the validation of automated sphygmomanometers. It specifies the requirements for clinical studies on the general population, as well as additional requirements for special populations, which might have physiologic characteristics that affect the accuracy of blood pressure measurements. This paper summarizes the statistical methodology behind the sample size required to test automated sphygmomanometers in these special populations and specifically addresses the pregnant patient population.
- 4 April 2023
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 28 (3) , 167-170
Statistical considerations for testing automated sphygmomanometers in special patient populations
The International Standards Organization 81060-2:2018 is the current global Standard for the validation of automated sphygmomanometers. It specifies the requirements for clinical studies on the general population, as well as additional requirements for special populations, which might have physiologic characteristics that affect the accuracy of blood pressure measurements. This paper summarizes the statistical methodology behind the sample size required to test automated sphygmomanometers in these special populations and specifically addresses the pregnant patient population.
- Open Access
- 13 February 2023
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 28 (2) , 113-115
Validation of the A&D UM-212BLE monitor according to ISO 81060-2, 2018: a device with clinically important programmability
Objective: The objective of this report was to describe the validation of the A&D UM-212BLE automated oscillometric sphygmomanometer to the ISO 81060-2, 2018 protocol. The device is specifically designed for enhanced office and out-of-office programmability. Methods: A combined pediatric (n = 35) and adult (n = 50) population was studied at Clinmark LLC in Louisville, Colorado, USA. Same-arm sequential testing was performed following the ISO 81060-2, 2018 requirements. Five cuffs were tested with a total arm circumference range from 12 to 50 cm. Reference readings were done by two blinded observers performing simultaneous auscultation. Results: For validation of Criterion 1 the mean ± SD (mmHg) of the device minus the reference differences were 3.94 ± 6.89 for SBP and 2.09 ± 6.68 for DBP. Both passed the Standard limits for Criterion 2; the systolic(S)SD achieved was 5.56 (5.70 permitted) and the diastolic(D)SD was 6.01 (6.62 permitted). All other Standard requirements were met. Conclusions: The UM-212BLE passed all requirements. The features that make this device clinically superior include settings for automated office BP, variable pressure inflation, dual measurement modes (oscillometry, auscultation), the wide range of cuffs tested, automated irregular heartbeat detection, and full validation in a pediatric population. The inclusion of all of these features makes the UM-212BLE a highly attractive device for both office and out-of-office BP estimation.
- 13 February 2023
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 28 (2) , 113-115
Open AccessValidation of the A&D UM-212BLE monitor according to ISO 81060-2, 2018: a device with clinically important programmability
Objective: The objective of this report was to describe the validation of the A&D UM-212BLE automated oscillometric sphygmomanometer to the ISO 81060-2, 2018 protocol. The device is specifically designed for enhanced office and out-of-office programmability. Methods: A combined pediatric (n = 35) and adult (n = 50) population was studied at Clinmark LLC in Louisville, Colorado, USA. Same-arm sequential testing was performed following the ISO 81060-2, 2018 requirements. Five cuffs were tested with a total arm circumference range from 12 to 50 cm. Reference readings were done by two blinded observers performing simultaneous auscultation. Results: For validation of Criterion 1 the mean ± SD (mmHg) of the device minus the reference differences were 3.94 ± 6.89 for SBP and 2.09 ± 6.68 for DBP. Both passed the Standard limits for Criterion 2; the systolic(S)SD achieved was 5.56 (5.70 permitted) and the diastolic(D)SD was 6.01 (6.62 permitted). All other Standard requirements were met. Conclusions: The UM-212BLE passed all requirements. The features that make this device clinically superior include settings for automated office BP, variable pressure inflation, dual measurement modes (oscillometry, auscultation), the wide range of cuffs tested, automated irregular heartbeat detection, and full validation in a pediatric population. The inclusion of all of these features makes the UM-212BLE a highly attractive device for both office and out-of-office BP estimation.
- Open Access
- 21 March 2022
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 24 (4) , 513-518
Validation of the A&D UA‐651 Plus/UA‐651SL Plus automated sphygmomanometer according to the ISO 81060–2, 2018 and ISO 81060–2 Amendment 1, 2020, which resulted in the currently pending Amendment to Amendment 1
In 2020 the ANSI/AAMI/ISO published Amendment 1 to the 81060–2 Standard. The purpose was to try to address issues relating to the distribution of subjects with respect to limb size ranges. It also required a new plot showing the limb circumferences on the x‐axis and the device minus reference errors on the y‐axis (Alpert plot). The study reported here showed inadequacies of the Amendment if significantly overlapping cuffs were to be tested. The innovative approach led to the testing of 135 subjects. Requirements for blood pressure (BP), arm circumference, and gender were fulfilled. The standard same arm sequential protocol was used. Criterion 1 calculations gave a mean ± standard deviation (SD) device minus manual BP values of 0.22 ± 7.90 mmHg for systolic BP and ‐0.68 ± 7.36 mmHg for diastolic BP. The maximum allowed mean value for either measurement is 5.0 mmHg. The SD values for Criterion 2 were 6.03 mmHg for systolic BP (maximum allowed 6.95) and 6.47 mmHg for diastolic BP (maximum allowed 6.90). All results passed the Standard requirements. This study demonstrated inadequacies of Amendment 1 and led to the development of an Amendment 2, still in the process of finalization. The new Amendment corrects the issues with significantly overlapping cuffs and “wide‐range” cuffs. The A&D UA‐651 Plus/UA‐651SL Plus BP monitors and the five cuffs not only passed the requirements of 81060–2:2018 and Amendment 1 but also a revised and more rigorous protocol with more subjects involved. These devices and cuffs can be used with confidence.
- 21 March 2022
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 24 (4) , 513-518
Open AccessValidation of the A&D UA‐651 Plus/UA‐651SL Plus automated sphygmomanometer according to the ISO 81060–2, 2018 and ISO 81060–2 Amendment 1, 2020, which resulted in the currently pending Amendment to Amendment 1
In 2020 the ANSI/AAMI/ISO published Amendment 1 to the 81060–2 Standard. The purpose was to try to address issues relating to the distribution of subjects with respect to limb size ranges. It also required a new plot showing the limb circumferences on the x‐axis and the device minus reference errors on the y‐axis (Alpert plot). The study reported here showed inadequacies of the Amendment if significantly overlapping cuffs were to be tested. The innovative approach led to the testing of 135 subjects. Requirements for blood pressure (BP), arm circumference, and gender were fulfilled. The standard same arm sequential protocol was used. Criterion 1 calculations gave a mean ± standard deviation (SD) device minus manual BP values of 0.22 ± 7.90 mmHg for systolic BP and ‐0.68 ± 7.36 mmHg for diastolic BP. The maximum allowed mean value for either measurement is 5.0 mmHg. The SD values for Criterion 2 were 6.03 mmHg for systolic BP (maximum allowed 6.95) and 6.47 mmHg for diastolic BP (maximum allowed 6.90). All results passed the Standard requirements. This study demonstrated inadequacies of Amendment 1 and led to the development of an Amendment 2, still in the process of finalization. The new Amendment corrects the issues with significantly overlapping cuffs and “wide‐range” cuffs. The A&D UA‐651 Plus/UA‐651SL Plus BP monitors and the five cuffs not only passed the requirements of 81060–2:2018 and Amendment 1 but also a revised and more rigorous protocol with more subjects involved. These devices and cuffs can be used with confidence.
- 3 March 2022
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 27 (2) , 77-78
Evolution of the standard for validation of automated sphygmomanometers
- 3 March 2022
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 27 (2) , 77-78
Evolution of the standard for validation of automated sphygmomanometers
- Open Access
- 12 February 2021
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 26 (3) , 234-236
Validation of the STEP deflation algorithm of the Midmark IQvitals Zone Vital Signs Monitor: part of a novel clinical ecosystem
Objectives: Assess the accuracy of the Midmark IQvitals Zone Vital Signs Monitor STEP deflation algorithm according to the ANSI/AAMI/ISO 81060-2 Standard. Methods: A total of 85 subjects completed the testing protocol. All standard requirements for gender, blood pressure (BP) values, and arm circumferences were met. Manual auscultation was performed by testers blinded to the device; the manual BP values were compared to the device readings. Results: The Standard Criterion 1 data analyses showed mean ± SD device minus manual BP values of 1.22 ± 6.3 mmHg for SBP and −1.67 ± 6.09 mmHg for DBP. The SD values for criterion 2 were 5.06 mmHg (SBP) and 4.98 mmHg (DBP). Conclusions: The device passed all Standard requirements. The Midmark IQvitals Zone device has features to improve accuracy and reduce or eliminate transcription errors and inaccuracy from improper patient positioning.
- 12 February 2021
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 26 (3) , 234-236
Open AccessValidation of the STEP deflation algorithm of the Midmark IQvitals Zone Vital Signs Monitor: part of a novel clinical ecosystem
Objectives: Assess the accuracy of the Midmark IQvitals Zone Vital Signs Monitor STEP deflation algorithm according to the ANSI/AAMI/ISO 81060-2 Standard. Methods: A total of 85 subjects completed the testing protocol. All standard requirements for gender, blood pressure (BP) values, and arm circumferences were met. Manual auscultation was performed by testers blinded to the device; the manual BP values were compared to the device readings. Results: The Standard Criterion 1 data analyses showed mean ± SD device minus manual BP values of 1.22 ± 6.3 mmHg for SBP and −1.67 ± 6.09 mmHg for DBP. The SD values for criterion 2 were 5.06 mmHg (SBP) and 4.98 mmHg (DBP). Conclusions: The device passed all Standard requirements. The Midmark IQvitals Zone device has features to improve accuracy and reduce or eliminate transcription errors and inaccuracy from improper patient positioning.
- Open Access
- 5 April 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (4) , 585-589
Evaluating the impact of motion artifact on noninvasive blood pressure devices
Most automated sphygmomanometers use oscillometric algorithms. Motion, either patient‐based or environmental, will affect the ability of a device to record an accurate blood pressure (BP). Members of the Association for the Advancement of Medical Instrumentation (AAMI) Sphygmomanometer Committee have been studying this problem for more than a decade. The AAMI TIR44 was the first publication to address the challenges of motion tolerance. The concepts described in TIR44 have led to the development of a draft of ISO 81060‐4, a new standard for testing devices for which the manufacturer wishes to claim motion tolerance. The current ISO 81060‐2 addresses both stress testing and 24‐hour ambulatory BP monitoring. Recent publications have reported on testing of devices in response to voluntary and involuntary patient motion. The ISO 81060‐4 will address testing in the presence of patient transport by ground, fixed‐wing, and rotary (helicopter) ambulances. The protocol will utilize noise profiles recorded under those three conditions. The profiles will be digitally stored on a library with free access. The proposed testing will be performed using patient simulators introducing the noise library files into known BP oscillometric envelopes. The specifications of the data capture and playback devices are specified, as is the evaluation statistical testing. The authors expect that the final draft will be published in 2020.
- 5 April 2020
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (4) , 585-589
Open AccessEvaluating the impact of motion artifact on noninvasive blood pressure devices
Most automated sphygmomanometers use oscillometric algorithms. Motion, either patient‐based or environmental, will affect the ability of a device to record an accurate blood pressure (BP). Members of the Association for the Advancement of Medical Instrumentation (AAMI) Sphygmomanometer Committee have been studying this problem for more than a decade. The AAMI TIR44 was the first publication to address the challenges of motion tolerance. The concepts described in TIR44 have led to the development of a draft of ISO 81060‐4, a new standard for testing devices for which the manufacturer wishes to claim motion tolerance. The current ISO 81060‐2 addresses both stress testing and 24‐hour ambulatory BP monitoring. Recent publications have reported on testing of devices in response to voluntary and involuntary patient motion. The ISO 81060‐4 will address testing in the presence of patient transport by ground, fixed‐wing, and rotary (helicopter) ambulances. The protocol will utilize noise profiles recorded under those three conditions. The profiles will be digitally stored on a library with free access. The proposed testing will be performed using patient simulators introducing the noise library files into known BP oscillometric envelopes. The specifications of the data capture and playback devices are specified, as is the evaluation statistical testing. The authors expect that the final draft will be published in 2020.
- Open Access
- 1 April 2019
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 24 (2) , 89-92
Validation of the Welch Allyn Home blood pressure monitor with professional SureBP algorithm with a special feature of accuracy during involuntary (tremor) patient movement
Current blood pressure (BP) measurement guidelines recommend certain patient requirements, especially keeping still for 5 min. Some patients cannot comply. My colleagues and I have reported accurate performance of the Welch Allyn SureBP algorithm for BP estimates during voluntary patient motion. No validation studies for involuntary patient movement (tremor) BP readings have been reported. This paper reports the validation of the Welch Allyn Home BP monitor, the 1700 Series, which contains that same SureBP algorithm, and the results of tremor testing as well. This device has multiple clinical advantages. Eighty-five patients (49 females) were studied using the ANSI/AAMI/ISO 81060-2, 2013 requirements. Three sizes of cuffs were included. The tremor experiments used a simulator programmed to frequency and amplitude of oscillometric impulses typically seen in patients with diseases causing tremors. This is the first protocol developed for this clinical scenario. The device uses an inflation-based algorithm, reducing discomfort and cycle times. The mean±SD for the device minus manual readings per ISO Criterion 1 were −2.93±6.64 mmHg for systolic BP and −2.453±5.48 mmHg for diastolic BP. The tremor testing was performed at low, normal, and high BP simulations. The device recorded a BP value for every cycle tested. The errors (device minus manual BP estimates) were quite low. The Welch Allyn Home BP monitor is accurate in the presence of involuntary patient motion (tremor). Clinicians can have a high level of confidence in the use of a self-measurement device, which operates using the same algorithm as contained in the ‘professional grade’ family of devices.
- 1 April 2019
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 24 (2) , 89-92
Open AccessValidation of the Welch Allyn Home blood pressure monitor with professional SureBP algorithm with a special feature of accuracy during involuntary (tremor) patient movement
Current blood pressure (BP) measurement guidelines recommend certain patient requirements, especially keeping still for 5 min. Some patients cannot comply. My colleagues and I have reported accurate performance of the Welch Allyn SureBP algorithm for BP estimates during voluntary patient motion. No validation studies for involuntary patient movement (tremor) BP readings have been reported. This paper reports the validation of the Welch Allyn Home BP monitor, the 1700 Series, which contains that same SureBP algorithm, and the results of tremor testing as well. This device has multiple clinical advantages. Eighty-five patients (49 females) were studied using the ANSI/AAMI/ISO 81060-2, 2013 requirements. Three sizes of cuffs were included. The tremor experiments used a simulator programmed to frequency and amplitude of oscillometric impulses typically seen in patients with diseases causing tremors. This is the first protocol developed for this clinical scenario. The device uses an inflation-based algorithm, reducing discomfort and cycle times. The mean±SD for the device minus manual readings per ISO Criterion 1 were −2.93±6.64 mmHg for systolic BP and −2.453±5.48 mmHg for diastolic BP. The tremor testing was performed at low, normal, and high BP simulations. The device recorded a BP value for every cycle tested. The errors (device minus manual BP estimates) were quite low. The Welch Allyn Home BP monitor is accurate in the presence of involuntary patient motion (tremor). Clinicians can have a high level of confidence in the use of a self-measurement device, which operates using the same algorithm as contained in the ‘professional grade’ family of devices.
- 1 February 2019
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 24 (1) , 42-44
Accurate blood pressure during patient arm movement
Current blood pressure (BP) measurement guidelines specify patient requirements, including being still. Some populations of patients cannot comply. A new International Organization for Standards is being developed to test devices that claim tolerance to transport-induced motion artifacts. This study proposes the first protocol to assess BP device accuracy in the presence of patient-induced motion. Forty healthy volunteers (23 males) participated. The device tested was the Welch Allyn Connex Spot Monitor (CSM) using the SureBP algorithm. A reusable cuff was placed on the left arm. During inflation/deflation cycles the participant performed pronation/supination movements of the left forearm every 5 s. The CSM readings during motion were compared to the average of manual resting auscultatory estimations immediately before and after each motion cycle (bracketing). The CSM recorded a BP reading on the first cycle in 37 participants. It displayed a reading in all 40 participants with one repeat cycle in the other three. The mean±SD for the device minus the manual BP values was 0.9±7.3 mmHg for systolic BP and −3.4±7.9 mmHg for diastolic BP. This study represents a proposal for an automated BP device assessment in the presence of patient-induced motion. The CSM device, which uses an inflation-based algorithm, routinely produced BP values that closely matched auscultatory values bracketed immediately before and after the motion-associated cycle. The CSM should be of significant clinical value in populations in whom resting ‘still’ readings are not usually feasible, such as pediatric and geriatric patients, and patients in pain from injury or illness.
- 1 February 2019
- Published by Wolters Kluwer Health in Blood Pressure Monitoring
- Vol. 24 (1) , 42-44
Accurate blood pressure during patient arm movement
Current blood pressure (BP) measurement guidelines specify patient requirements, including being still. Some populations of patients cannot comply. A new International Organization for Standards is being developed to test devices that claim tolerance to transport-induced motion artifacts. This study proposes the first protocol to assess BP device accuracy in the presence of patient-induced motion. Forty healthy volunteers (23 males) participated. The device tested was the Welch Allyn Connex Spot Monitor (CSM) using the SureBP algorithm. A reusable cuff was placed on the left arm. During inflation/deflation cycles the participant performed pronation/supination movements of the left forearm every 5 s. The CSM readings during motion were compared to the average of manual resting auscultatory estimations immediately before and after each motion cycle (bracketing). The CSM recorded a BP reading on the first cycle in 37 participants. It displayed a reading in all 40 participants with one repeat cycle in the other three. The mean±SD for the device minus the manual BP values was 0.9±7.3 mmHg for systolic BP and −3.4±7.9 mmHg for diastolic BP. This study represents a proposal for an automated BP device assessment in the presence of patient-induced motion. The CSM device, which uses an inflation-based algorithm, routinely produced BP values that closely matched auscultatory values bracketed immediately before and after the motion-associated cycle. The CSM should be of significant clinical value in populations in whom resting ‘still’ readings are not usually feasible, such as pediatric and geriatric patients, and patients in pain from injury or illness.